Roger Longman, Founder and Chairman
Roger Longman is co-founder and chairman of Real Endpoints LLC, a leading reimbursement-focused analytics and advisory firm.
Roger is recognized as an expert in biopharmaceutical strategy and reimbursement and often speaks at key industry events organized by important trade organizations, investment banks, venture capital firms, and leading biopharma companies.
He has been involved with the health-care industry for more than 30 years. At his first venture, the co-founding of Windhover Information, he and his team created a number of industry-standard analytical sources, including must-read strategy publications such as IN VIVO and Start-Up, the strategic transactions database and a major conference business for senior executives. The business was acquired by Elsevier where for two years Longman ran the company’s pharmaceutical business information group.
Roger co-founded Real Endpoints in 2011. Since then, RE has developed a number of value-based approaches to developing and commercializing drugs and diagnostics – including proprietary tools for objective analysis of drug value; innovative contracting structures and processes for negotiating, monitoring, and reconciling the agreements; the RE Marketplace platform; and objective assessments of, and development of strategies for, patient- and provider-support services, including a new patient-support database focusing on Medicare patients, RE Assist.
He lectures regularly at several leading universities and co-directed the Wharton-Windhover pharmaceutical program at The Wharton School of the University of Pennsylvania. Mr. Longman completed his BA at Cornell University and MA in English Literature at the University of North Carolina at Chapel Hill, then taught for three years at the European division of the University of Maryland.